Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NBP
NBP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NBP News
I-Mab Biopharma Reports FY GAAP EPS
Apr 07 2026
seekingalpha
NovaBridge Successfully Transforms into a Global Biotech Platform
Apr 07 2026
Newsfilter
NOVABRIDGE ANNOUNCES 2025 FULL YEAR FINANCIAL RESULTS AND BUSINESS UPDATE
Apr 07 2026
moomoo
NovaBridge Secures FDA Confirmation for Accelerated Approval Potential of Givastomig
Mar 17 2026
Newsfilter
NovaBridge Biosciences Reports Positive Phase 2a Results for VIS-101
Mar 09 2026
Benzinga
Ooma Inc Reports Strong Q4 Earnings, Shares Surge
Mar 05 2026
Benzinga
NovaBridge Announces VIS-101 Clinical Data Update
Mar 03 2026
Newsfilter
Wall Street Analysts Adjust Ratings
Feb 06 2026
Benzinga
NovaBridge Biosciences' Chairman Plans to Buy $5 Million in ADSs
Jan 20 2026
Newsfilter
GT Biopharma Submits IND for GTB-5550 Targeting $362 Billion Solid Tumor Market
Jan 16 2026
PRnewswire
NovaBridge Reports Positive Phase 1b Results for Givastomig in Gastric Cancer with 77% Response Rate
Jan 06 2026
Benzinga
NovaBridge Biosciences Reports 77% Response Rate in HER2-Negative Gastric Cancer Study
Jan 06 2026
NASDAQ.COM
NovaBridge Joins Nasdaq Biotech Index, Kicking Off 2026 with Strategic Visibility
Dec 30 2025
Globenewswire
NovaBridge Joins Nasdaq Biotech Index, Kicking Off 2026 with Strategic Visibility
Dec 30 2025
Newsfilter
NovaBridge Unveils Encouraging Phase 1 Dose Expansion Results at ESMO-IO
Dec 11 2025
Yahoo Finance
NovaBridge Presents Ragistomig Data, Q6W Dosing Enhances Safety Profile
Dec 10 2025
Globenewswire
Show More News
